Bright Minds Biosciences Inc.

DRUG

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001827401

SEC filings (opens in a new tab)

No open-market purchases or sales by Bright Minds Biosciences Inc. insiders were filed in the last 90 days; 99 institutions reported holding it in 13F filings for Q2 2026, worth $653.8M in total; no superinvestor holds it.

Q3 2025 vs. Q2 2025

How the institutions holding Bright Minds Biosciences Inc. changed between Q2 2025 and Q3 2025.

All holders in Q3 2025 All holders in Q2 2025

13F holders of DRUG: Q2 2025 compared with Q3 2025
Measure	Q2 2025	Q3 2025	Change
Holders	47	64	+17
Shares	5.24M	6.04M	+804.2K (+15.4%)
Value	$137.0M	$366.1M	+$229.1M (+167.3%)

New holders (18)

Institutions that held Bright Minds Biosciences Inc. at the end of Q3 2025 but not at the end of Q2 2025.

Institutions new to DRUG in Q3 2025
Institution	Shares	Value	% of portfolio
Braidwell LP	303,685	$18.4M	0.55%
Balyasny Asset Management LLC	186,922	$11.3M	0.02%
Superstring Capital Management LP	53,950	$3.27M	3.22%
Jane Street Group, LLC	15,903	$964.7K	0.00%
Two Sigma Investments, LP	10,711	$649.7K	0.00%
Summit Wealth Group LLC	6,149	$418.4K	0.06%
Citadel Advisors LLC	6,476	$392.8K	0.00%
LPL Financial LLC	5,645	$342.4K	0.00%
State Board of Administration of Florida Retirement System	3,781	$229.4K	0.00%
Renaissance Technologies LLC	3,500	$212.3K	0.00%
MetLife Investment Management	2,918	$177.0K	0.00%
Gordian Capital Singapore Pte Ltd	1,200	$72.8K	0.10%
Russell Investments Group, Ltd.	951	$57.7K	0.00%
Tower Research Capital LLC (TRC)	271	$16.4K	0.00%
Global Retirement Partners, LLC	200	$12.1K	0.00%
SRS Capital Advisors, Inc.	24	$1.46K	0.00%
The PNC Financial Services Group, Inc.	9	$546	0.00%
CWM, LLC	6	$0	0.00%

Sold out (1)

Institutions that held Bright Minds Biosciences Inc. at the end of Q2 2025 and filed for Q3 2025 without it.

Institutions that sold out of DRUG in Q3 2025
Institution	Shares, Q2 2025	Value, Q2 2025
Readystate Asset Management LP	13,975	$364.9K